Adrenocortical carcinoma staging: Difference between revisions
No edit summary |
No edit summary |
||
Line 69: | Line 69: | ||
|- | |- | ||
| M1||Distant metastasis | | M1||Distant metastasis | ||
|} | |||
==Staging== | |||
<br> | |||
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center | |||
|+'''''Thyroid TNM staging''''' | |||
! style="background: #4479BA; width: 120px;" | {{fontcolor|#FFF|Stage}} | |||
! style="background: #4479BA; width: 550px;" | {{fontcolor|#FFF|Description}} | |||
|- | |||
! style="background: #DCDCDC;" |TX | |||
! style="background: #F5F5F5;" |Primary [[tumor]] cannot be assessed | |||
|- | |||
! style="background: #DCDCDC;" |T0 | |||
! style="background: #F5F5F5;" |No evidence of primary [[tumor]] | |||
|- | |||
! style="background: #DCDCDC;" |T1 | |||
! style="background: #F5F5F5;" |[[Tumor]] ≤2 cm in greatest dimension limited to the [[thyroid]] | |||
|- | |||
! style="background: #DCDCDC;" |T1a | |||
! style="background: #F5F5F5;" |[[Tumor]] ≤1 cm, limited to the [[thyroid]] | |||
|- | |||
! style="background: #DCDCDC;" |T1b | |||
! style="background: #F5F5F5;" |[[Tumor]] >1 cm but ≤2 cm in greatest dimension, limited to the [[thyroid]] | |||
|- | |||
! style="background: #DCDCDC;" |T2 | |||
! style="background: #F5F5F5;" |[[Tumor]] >2 cm but ≤4 cm in greatest dimension, limited to the [[thyroid]] | |||
|- | |||
! style="background: #DCDCDC;" |T3 | |||
! style="background: #F5F5F5;" |[[Tumor]] >4 cm in greatest dimension limited to the [[thyroid]] or any [[tumor]] with minimal extrathyroid extension (e.g., extension to [[sternothyroid muscle]] or perithyroid soft tissues) | |||
|- | |||
! style="background: #DCDCDC;" rowspan=2|T4a | |||
! style="background: #F5F5F5;" |Moderately advanced [[disease]] | |||
|- | |||
! style="background: #F5F5F5;" |[[Tumor]] of any size extending beyond the thyroid capsule to invade subcutaneous [[soft tissue]]s, [[larynx]], [[trachea]], [[esophagus]], or [[recurrent laryngeal nerve]] | |||
|- | |||
! style="background: #DCDCDC;" rowspan=2|T4b | |||
! style="background: #F5F5F5;" |Very advanced [[disease]] | |||
|- | |||
! style="background: #F5F5F5;" |[[Tumor]] invades prevertebral fascia or encases [[carotid artery]] or mediastinal vessel | |||
|} | |||
<br> | |||
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center | |||
|+'''''Regional Lymph Nodes (N)''''' | |||
! style="background: #4479BA; width: 120px;" | {{fontcolor|#FFF|Stage}} | |||
! style="background: #4479BA; width: 550px;" | {{fontcolor|#FFF|Description}} | |||
|- | |||
! style="background: #DCDCDC;" |NX | |||
! style="background: #F5F5F5;" |Regional [[lymph node]] cannot be assessed | |||
|- | |||
! style="background: #DCDCDC;" |N0 | |||
! style="background: #F5F5F5;" |No regional lymph node metastasis]] | |||
|- | |||
! style="background: #DCDCDC;" |N1 | |||
! style="background: #F5F5F5;" |Regional [[lymph node]] metastasis | |||
|- | |||
! style="background: #DCDCDC;" |N1a | |||
! style="background: #F5F5F5;" |[[Metastases]] to Level VI (pretracheal, paratracheal, and prelaryngeal/Delphian lymph nodes) | |||
|- | |||
! style="background: #DCDCDC;" |N1b | |||
! style="background: #F5F5F5;" |[[Metastases]] to unilateral, bilateral, or contralateral cervical (Levels I, II, III, IV, or V) or retropharyngeal or superior mediastinal lymph nodes (Level VII) | |||
|} | |||
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center | |||
|+'''''Distant Metastasis (M)''''' | |||
! style="background: #4479BA; width: 120px;" | {{fontcolor|#FFF|Stage}} | |||
! style="background: #4479BA; width: 550px;" | {{fontcolor|#FFF|Description}} | |||
|- | |||
! style="background: #DCDCDC;" |M0 | |||
! style="background: #F5F5F5;" |No distant [[metastasis]] | |||
|- | |||
! style="background: #DCDCDC;" |M1 | |||
! style="background: #F5F5F5;" |Distant [[metastasis]] | |||
|} | |||
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center | |||
|+'''''Anatomic Stage/Prognostic Groups''''' | |||
! style="background: #4479BA; width: 120px;" | {{fontcolor|#FFF|Stage}} | |||
! style="background: #4479BA; width: 550px;" | {{fontcolor|#FFF|T}} | |||
! style="background: #4479BA; width: 550px;" | {{fontcolor|#FFF|N}} | |||
! style="background: #4479BA; width: 550px;" | {{fontcolor|#FFF|M}} | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" colspan=4 align=center| '''Papillary thyroid carcinoma''' | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" colspan=4 | '''YOUNGER THAN 45 YEARS''' | |||
|- | |||
! style="background: #DCDCDC;" |I | |||
! style="background: #F5F5F5;" |Any T | |||
! style="background: #F5F5F5;" |Any N | |||
! style="background: #F5F5F5;" |M0 | |||
|- | |||
! style="background: #DCDCDC;" |II | |||
! style="background: #F5F5F5;" |Any T | |||
! style="background: #F5F5F5;" |Any N | |||
! style="background: #F5F5F5;" |M1 | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" colspan=4 | '''45 YEARS AND OLDER''' | |||
|- | |||
! style="background: #DCDCDC;" |I | |||
! style="background: #F5F5F5;" |T1 | |||
! style="background: #F5F5F5;" |Any N | |||
! style="background: #F5F5F5;" |M1 | |||
|- | |||
! style="background: #DCDCDC;" |II | |||
! style="background: #F5F5F5;" |T2 | |||
! style="background: #F5F5F5;" |N0 | |||
! style="background: #F5F5F5;" |M0 | |||
|- | |||
! style="background: #DCDCDC;" |III | |||
! style="background: #F5F5F5;" |T3 | |||
! style="background: #F5F5F5;" |N0 | |||
! style="background: #F5F5F5;" |M0 | |||
|- | |||
! style="background: #DCDCDC;" | | |||
! style="background: #F5F5F5;" |T1 | |||
! style="background: #F5F5F5;" |N1a | |||
! style="background: #F5F5F5;" |M0 | |||
|- | |||
! style="background: #DCDCDC;" | | |||
! style="background: #F5F5F5;" |T2 | |||
! style="background: #F5F5F5;" |N1a | |||
! style="background: #F5F5F5;" |M0 | |||
|- | |||
! style="background: #DCDCDC;" | | |||
! style="background: #F5F5F5;" |T3 | |||
! style="background: #F5F5F5;" |N1a | |||
! style="background: #F5F5F5;" |M0 | |||
|- | |||
! style="background: #DCDCDC;" |IVA | |||
! style="background: #F5F5F5;" |T4a | |||
! style="background: #F5F5F5;" |N0 | |||
! style="background: #F5F5F5;" |M0 | |||
|- | |||
! style="background: #DCDCDC;" | | |||
! style="background: #F5F5F5;" |T4a | |||
! style="background: #F5F5F5;" |N1a | |||
! style="background: #F5F5F5;" |M0 | |||
|- | |||
! style="background: #DCDCDC;" | | |||
! style="background: #F5F5F5;" |T1 | |||
! style="background: #F5F5F5;" |N1b | |||
! style="background: #F5F5F5;" |M0 | |||
|- | |||
! style="background: #DCDCDC;" | | |||
! style="background: #F5F5F5;" |T2 | |||
! style="background: #F5F5F5;" |N1b | |||
! style="background: #F5F5F5;" |M0 | |||
|- | |||
! style="background: #DCDCDC;" | | |||
! style="background: #F5F5F5;" |T3 | |||
! style="background: #F5F5F5;" |N1b | |||
! style="background: #F5F5F5;" |M0 | |||
|- | |||
! style="background: #DCDCDC;" | | |||
! style="background: #F5F5F5;" |T4a | |||
! style="background: #F5F5F5;" |N1b | |||
! style="background: #F5F5F5;" |M0 | |||
|- | |||
! style="background: #DCDCDC;" |IVB | |||
! style="background: #F5F5F5;" |T4b | |||
! style="background: #F5F5F5;" |Any N | |||
! style="background: #F5F5F5;" |M0 | |||
|- | |||
! style="background: #DCDCDC;" |Stage IVC | |||
! style="background: #F5F5F5;" |Any T | |||
! style="background: #F5F5F5;" |Any N | |||
! style="background: #F5F5F5;" |M1 | |||
|} | |} | ||
Revision as of 13:46, 18 September 2017
Adrenocortical carcinoma Microchapters |
Differentiating Adrenocortical carcinoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Study |
Adrenocortical carcinoma staging On the Web |
American Roentgen Ray Society Images of Adrenocortical carcinoma staging |
Risk calculators and risk factors for Adrenocortical carcinoma staging |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]
Overview
According to the TNM staging system, there are four stages of adrenocortical cancer based on the tumor size, lymph nodes, and distant metastasis. Each stage is assigned a number and letter that designates the number of lymph nodes involved and presence/absence of distant metastasis.
Staging of adrenocortical carcinoma
The AJCC has designated staging by TNM to define adrenocortical carcinoma
Staging according to TNM staging system
Stage | T | N | M |
I | T1 | N0 | M0 |
II | T2 | N0 | M0 |
III | T1 | N1 | M0 |
T2 | N1 | M0 | |
T3 | N0 | M0 | |
IV | T3 | N1 | M0 |
T4 | N0 | M0 | |
T4 | N1 | M0 | |
Any T | Any N | M1 |
Tumor size (T)
TX | Primary tumor cannot be assessed |
T0 | No evidence of primary tumor |
T1 | Tumor ≤5 cm in greatest dimension, no extra-adrenal invasion |
T2 | Tumor >5 cm, no extra-adrenal invasion |
T3 | Tumor of any size with local invasion, but not invading adjacent organs |
T4 | Tumor of any size with invasion of adjacent organs |
Lymph nodes (N)
NX | Regional lymph nodes cannot be assessed |
N0 | No regional lymph node metastasis |
N1 | Metastases in regional lymph node(s) |
Metastasis (M)
M0 | No distant metastasis |
M1 | Distant metastasis |
Staging
Stage | Description |
---|---|
TX | Primary tumor cannot be assessed |
T0 | No evidence of primary tumor |
T1 | Tumor ≤2 cm in greatest dimension limited to the thyroid |
T1a | Tumor ≤1 cm, limited to the thyroid |
T1b | Tumor >1 cm but ≤2 cm in greatest dimension, limited to the thyroid |
T2 | Tumor >2 cm but ≤4 cm in greatest dimension, limited to the thyroid |
T3 | Tumor >4 cm in greatest dimension limited to the thyroid or any tumor with minimal extrathyroid extension (e.g., extension to sternothyroid muscle or perithyroid soft tissues) |
T4a | Moderately advanced disease |
Tumor of any size extending beyond the thyroid capsule to invade subcutaneous soft tissues, larynx, trachea, esophagus, or recurrent laryngeal nerve | |
T4b | Very advanced disease |
Tumor invades prevertebral fascia or encases carotid artery or mediastinal vessel |
Stage | Description |
---|---|
NX | Regional lymph node cannot be assessed |
N0 | No regional lymph node metastasis]] |
N1 | Regional lymph node metastasis |
N1a | Metastases to Level VI (pretracheal, paratracheal, and prelaryngeal/Delphian lymph nodes) |
N1b | Metastases to unilateral, bilateral, or contralateral cervical (Levels I, II, III, IV, or V) or retropharyngeal or superior mediastinal lymph nodes (Level VII) |
Stage | Description |
---|---|
M0 | No distant metastasis |
M1 | Distant metastasis |
Stage | T | N | M |
---|---|---|---|
Papillary thyroid carcinoma | |||
YOUNGER THAN 45 YEARS | |||
I | Any T | Any N | M0 |
II | Any T | Any N | M1 |
45 YEARS AND OLDER | |||
I | T1 | Any N | M1 |
II | T2 | N0 | M0 |
III | T3 | N0 | M0 |
T1 | N1a | M0 | |
T2 | N1a | M0 | |
T3 | N1a | M0 | |
IVA | T4a | N0 | M0 |
T4a | N1a | M0 | |
T1 | N1b | M0 | |
T2 | N1b | M0 | |
T3 | N1b | M0 | |
T4a | N1b | M0 | |
IVB | T4b | Any N | M0 |
Stage IVC | Any T | Any N | M1 |